182 related articles for article (PubMed ID: 16075198)
1. [Aftercare in testicular cancer is worthwhile. Recurrences are curable].
Pottek TS; Dieckmann KP
Urologe A; 2005 Sep; 44(9):1024-30. PubMed ID: 16075198
[TBL] [Abstract][Full Text] [Related]
2. [Penile cancer--aftercare with results. How much is necessary?].
Paul R; van Randenborgh H; Schöler S; May F; Hartung R
Urologe A; 2005 Sep; 44(9):1031-6. PubMed ID: 16075197
[TBL] [Abstract][Full Text] [Related]
3. [When is aftercare useful in renal cell cancer?].
Ebert T; Fischer C
Urologe A; 2005 Sep; 44(9):1018, 1020-3. PubMed ID: 16047197
[TBL] [Abstract][Full Text] [Related]
4. [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].
Heine K; Wolff JM
Urologe A; 2005 Sep; 44(9):1009-12, 1014-7. PubMed ID: 16096743
[TBL] [Abstract][Full Text] [Related]
5. [Aftercare or not--that is the question!].
Schubert-Fritschle G; Weissbach L; Hölzel D
Urologe A; 2005 Sep; 44(9):991-6. PubMed ID: 16049723
[TBL] [Abstract][Full Text] [Related]
6. [Therapy for recurrent testicular cancer].
Kuczyk M; Horstmann M; Merseburger A; Beyer J
Urologe A; 2005 Apr; 44(4):352-7. PubMed ID: 15756533
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis, treatment and follow-up of testicular cancer].
Krege S
Urologe A; 2017 Dec; 56(12):1623-1636. PubMed ID: 29188346
[TBL] [Abstract][Full Text] [Related]
8. [PSA recurrence after primary curative therapy--local or systemic? When is a second curative therapy still possible?].
Wirth MP; Engelhardt FM
Urologe A; 2005 Sep; 44(9):997-1004, 1006-7. PubMed ID: 16133232
[TBL] [Abstract][Full Text] [Related]
9. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.
Honecker F; Aparicio J; Berney D; Beyer J; Bokemeyer C; Cathomas R; Clarke N; Cohn-Cedermark G; Daugaard G; Dieckmann KP; Fizazi K; Fosså S; Germa-Lluch JR; Giannatempo P; Gietema JA; Gillessen S; Haugnes HS; Heidenreich A; Hemminki K; Huddart R; Jewett MAS; Joly F; Lauritsen J; Lorch A; Necchi A; Nicolai N; Oing C; Oldenburg J; Ondruš D; Papachristofilou A; Powles T; Sohaib A; Ståhl O; Tandstad T; Toner G; Horwich A
Ann Oncol; 2018 Aug; 29(8):1658-1686. PubMed ID: 30113631
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of testicular cancer].
Krege S; Hartmann JT; Rübben H
Urologe A; 2006 May; 45(5):600-4. PubMed ID: 16612645
[TBL] [Abstract][Full Text] [Related]
11. [Risk-guided after-care of testicular tumor].
Schölermann KH; Dettmann R; Hartmann M
Urologe A; 1996 Jul; 35(4):326-30. PubMed ID: 8928363
[TBL] [Abstract][Full Text] [Related]
12. [Results of close testicular tumor after-care].
Erpenbach K; Derschum W; Reis M; von Vietsch H
Urologe A; 1990 Mar; 29(2):102-7; discussion 107-9. PubMed ID: 2158683
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy for germ cell cancer].
Beyer J; Bokemeyer C
Urologe A; 2004 Dec; 43(12):1507-13. PubMed ID: 15592707
[TBL] [Abstract][Full Text] [Related]
14. Late relapse of nonseminomatous germ cell tumours.
Oldenburg J; Fosså SD
BJU Int; 2009 Nov; 104(9 Pt B):1413-7. PubMed ID: 19840022
[TBL] [Abstract][Full Text] [Related]
15. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis.
Edelman MJ; Meyers FJ; Siegel D
J Gen Intern Med; 1997 May; 12(5):318-31. PubMed ID: 9159703
[TBL] [Abstract][Full Text] [Related]
16. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
17. [Follow-up recommendations for patients after curative treatment of invasive breast cancer].
Zuber M; Viehl CT; Güller U; Langer I
Ther Umsch; 2008 Jun; 65(6):319-21. PubMed ID: 18622954
[TBL] [Abstract][Full Text] [Related]
18. [Testicular recurrences in acute leukemia].
Ortega Aramburu JJ
Med Clin (Barc); 1984 May; 82(20):889-92. PubMed ID: 6748790
[No Abstract] [Full Text] [Related]
19. [Post-therapeutic care: when is it worthwhile?].
Gehbauer G
MMW Fortschr Med; 2007 Sep; 149(35-36):32-4. PubMed ID: 17948376
[TBL] [Abstract][Full Text] [Related]
20. [Follow-up after malignant tumours of the uterus (cancer of the uterine corpus / cervical cancer)].
Johann S; Mueller MD
Ther Umsch; 2008 Jun; 65(6):341-6. PubMed ID: 18622958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
